A Phase I/II Clinical Study of SHR-4298 Injection in Patients With Malignant Solid Tumors
Clinical trial NCT07229612 · RECRUITING
Trial details
- NCT number
- NCT07229612
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-03
- Primary completion
- 2028-11-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.